Last reviewed · How we verify
NCT05684458
The Effect of Reiki on Symptom Control and Quality of Life in Breast Cancer Patients
NA trial testing Reiki in Breast Cancer in 52 participants. Status unknown.
30 July 2023
Quick facts
| Lead sponsor | Ankara Medipol University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 52 |
| Start date | 1 February 2023 |
| Primary completion | 30 July 2023 |
| Estimated completion | 31 August 2023 |
Drugs / interventions tested
- Reiki
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Symptoms and Signs — all drugs for Symptoms and Signs →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Ankara Medipol University
Who can join
18 and older, female only, with Breast Cancer or Symptoms and Signs. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to examine the effect of Reiki on symptom control and quality of life in breast cancer patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05684458
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Reiki
Trials testing the same drug.
- NCT07193784 — Effect of Reiki Applied After Coronary Angiography on Pain and Comfort Level · NA · completed
- NCT07254520 — The Effects of Reiki Therapy in Infants With Colic · NA · recruiting
- NCT07083856 — Effects of Reiki and Self-Acupressure Applications · NA · recruiting
- NCT06526949 — The Effect of Reiki on Pain, Anxiety and Haemodynamic Parameters in Patients Receiving Mechanical Ventilator Support · NA · completed
- NCT06354049 — Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI) · NA · completed
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Ankara Medipol University trials
Trials by the same sponsor.
- NCT07307885 — The Effect of Photobiomodulation on Pressure Ulcers · NA · not yet recruiting
- NCT07304609 — "Effect of LEGO® Serious Play® Trauma-Informed Care Training on Nursing Students · NA · not yet recruiting
- NCT07344857 — Prenatal Pilates and Postpartum Ligamentous Laxity · completed
- NCT06765304 — Preconceptional Period and Transtheoretically Based Education · NA · completed
- NCT07133009 — Intentional Relationship Model in OT Students · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05684458 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Medipol University
- Last refreshed: 13 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05684458.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing